Fig. 1
From: Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS
Different rates of neurological progression among non-progressors (NP), moderate progressors (MP), and rapid progressors (RP). Seropositive nondemented cases are not shown since they have no survival value. The mean Memorial Sloan-Kettering (MSK) slope of the NP, MP, and RP groups was 0.000747 (±0.000606), 0.00461 (±0.00156), and 0.016842 (±0.003286), respectively. The median MSK slope of each group was 0.000557, 0.00349, and 0.01608, respectively (NP and MP, p ≤ 0.0064; NP and RP, p ≤ 0.0109; MP and RP, p ≤ 0.005). *Survival for case 279 and 514 was 21 and 59.2 months, respectively.